Our previous studies indicated that protective immunity against HTNV involved strong epitope-specific CD8+ T-cell responses, promoting the clearance of the virus both in ex vivo HFRS patients and in vivo animal models [20, 21, 23]. This evidence concerns the gene CD8A and hemorrhagic fever with renal syndrome.